Page last updated: 2024-10-21

3-aminobenzamide and Osteogenic Sarcoma

3-aminobenzamide has been researched along with Osteogenic Sarcoma in 4 studies

Research Excerpts

ExcerptRelevanceReference
" In the present study, we investigate the effects of 3-aminobenzamide (3-AB), a potent inhibitor of PARP, on human osteosarcoma cells and whether or not it can sensitize the tumor cells to chemotherapeutic agents."7.77The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells. ( Peng, F; Wu, H; Xu, XQ; Yu, JZ; Zheng, YD, 2011)
"A novel cancer stem-like cell line (3AB-OS), expressing a number of pluripotent stem cell markers, was irreversibly selected from human osteosarcoma MG-63 cells by long-term treatment (100 days) with 3-aminobenzamide (3AB)."7.75Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. ( De Blasio, A; Di Fiore, R; Ferrante, RD; Giuliano, M; Messina, C; Pirozzi, G; Santulli, A; Tesoriere, G; Tirino, V; Vento, R, 2009)
"This study demonstrates that in human osteosarcoma cells treatment with 3-aminobenzamide (3-AB), a potent inhibitor of poly(ADP-ribose) polymerase (PARP), induces morphological and biochemical features of differentiation, the duration of which depends on whether or not the normal RB gene is expressed."7.72The effect of 3-aminobenzamide, inhibitor of poly(ADP-ribose) polymerase, on human osteosarcoma cells. ( D'Anneo, A; De Blasio, A; Emanuele, S; Giuliano, M; Lauricella, M; Musmeci, MT; Tesoriere, G; Vassallo, B; Vento, R, 2003)
" In the present study, we investigate the effects of 3-aminobenzamide (3-AB), a potent inhibitor of PARP, on human osteosarcoma cells and whether or not it can sensitize the tumor cells to chemotherapeutic agents."3.77The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells. ( Peng, F; Wu, H; Xu, XQ; Yu, JZ; Zheng, YD, 2011)
"A novel cancer stem-like cell line (3AB-OS), expressing a number of pluripotent stem cell markers, was irreversibly selected from human osteosarcoma MG-63 cells by long-term treatment (100 days) with 3-aminobenzamide (3AB)."3.75Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. ( De Blasio, A; Di Fiore, R; Ferrante, RD; Giuliano, M; Messina, C; Pirozzi, G; Santulli, A; Tesoriere, G; Tirino, V; Vento, R, 2009)
"This study demonstrates that in human osteosarcoma cells treatment with 3-aminobenzamide (3-AB), a potent inhibitor of poly(ADP-ribose) polymerase (PARP), induces morphological and biochemical features of differentiation, the duration of which depends on whether or not the normal RB gene is expressed."3.72The effect of 3-aminobenzamide, inhibitor of poly(ADP-ribose) polymerase, on human osteosarcoma cells. ( D'Anneo, A; De Blasio, A; Emanuele, S; Giuliano, M; Lauricella, M; Musmeci, MT; Tesoriere, G; Vassallo, B; Vento, R, 2003)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Fiore, R1
Santulli, A2
Ferrante, RD1
Giuliano, M2
De Blasio, A3
Messina, C2
Pirozzi, G1
Tirino, V1
Tesoriere, G3
Vento, R3
Zheng, YD1
Xu, XQ1
Peng, F1
Yu, JZ1
Wu, H1
Musmeci, MT1
Lauricella, M1
Emanuele, S1
D'Anneo, A2
Vassallo, B1
Mangano, V1
Di Leonardo, E1

Other Studies

4 other studies available for 3-aminobenzamide and Osteogenic Sarcoma

ArticleYear
Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.
    Journal of cellular physiology, 2009, Volume: 219, Issue:2

    Topics: Adolescent; Adult; Apoptosis; ATP-Binding Cassette Transporters; Benzamides; Benzimidazoles; Biomark

2009
The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells.
    Oncology reports, 2011, Volume: 25, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; C

2011
The effect of 3-aminobenzamide, inhibitor of poly(ADP-ribose) polymerase, on human osteosarcoma cells.
    International journal of oncology, 2003, Volume: 23, Issue:6

    Topics: Alkaline Phosphatase; Apoptosis; bcl-2-Associated X Protein; Benzamides; Blotting, Western; Caspase

2003
Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells.
    FEBS letters, 2005, Jan-31, Volume: 579, Issue:3

    Topics: Adenosine Diphosphate Ribose; Base Sequence; Benzamides; Blotting, Western; Cell Cycle Proteins; Cel

2005